| Literature DB >> 28085912 |
Ji Sun Lee1,2, Soo Hee Cho3, Chae Mi Lim4, Moon Ik Chang5, Hyun Jin Joo4, Hojae Bae6, Hyun Jin Park2,7.
Abstract
A confirmatory and quantitative method of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the determination of mebendazole and its hydrolyzed and reduced metabolites in pork, chicken, and horse muscles was developed and validated in this study. Anthelmintic compounds were extracted with ethyl acetate after sample mixture was made alkaline followed by liquid chromatographic separation using a reversed phase C18 column. Gradient elution was performed with a mobile phase consisting of water containing 10 mM ammonium formate and methanol. This confirmatory method was validated according to EU requirements. Evaluated validation parameters included specificity, accuracy, precision (repeatability and within-laboratory reproducibility), analytical limits (decision limit and detection limit), and applicability. Most parameters were proved to be conforming to the EU requirements. The decision limit (CCα) and detection capability (CCβ) for all analytes ranged from 15.84 to 17.96 μgkg-1. The limit of detection (LOD) and the limit of quantification (LOQ) for all analytes were 0.07 μgkg-1 and 0.2 μgkg-1, respectively. The developed method was successfully applied to monitoring samples collected from the markets in major cities and proven great potential to be used as a regulatory tool to determine mebendazole residues in animal based foods.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28085912 PMCID: PMC5234820 DOI: 10.1371/journal.pone.0169597
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Maximum residue limits (MRLs) of mebendazole residues.
| Pharmacologically Active Substance | Marker Residue | Animal Species | MRLs | Target Tissues | Therapeutic Classification |
|---|---|---|---|---|---|
| Mebendazole | Sum of mebendazole, methyl(5-(1-hydroxy, 1-phenyl)methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents | • Ovine | • 60 μg/kg | • Muscle | Antiparasitic agents /Agents against endoparasites |
* Not for use in animals from which milk is produced for human consumption.
Fig 1Molecular structures of examined benzimidazoles.
Gradient elution profile.
| Time(min) | A(%) | B(%) |
|---|---|---|
| 0 | 70 | 30 |
| 0.5 | 70 | 30 |
| 4.0 | 5 | 95 |
| 7.0 | 5 | 95 |
| 7.1 | 70 | 30 |
| 10.0 | 70 | 30 |
amobile phase A: 10 mM Ammonium formate.
bmobile phase B: methanol.
Summary of diagnostic ions and mass operating parameters.
| Compound | Precursor ion(m/z) | Product ions(m/z) | Collision energy (eV) |
|---|---|---|---|
| Mebendazole (MEB) | 296 | 264 | 31 |
| 105 | 49 | ||
| 5-OH-Mebendazole (RMEB) | 298 | 160 | 59 |
| 266 | 49 | ||
| Mebendazole-amine (HMEB) | 238 | 77 | 49 |
| 105 | 33 | ||
| 5-OH-Mebendazole-d3 | 301 | 79 | 55 |
| 266 | 55 |
Fig 2Effect of sample purification method on MEB, HMEB, and RMEB recovery in pork spiked at the concentration of 30 μgkg-1.
Fig 3Changes in the intensity of MEB, HMEB, and RMEB in pork spiked at the concentration of 30 μgkg-1 with different additives (0.1% Formic acid, 20 mM Ammonium formate, and 10 mM Ammonium formate).
Fig 4MS/MS (MS2 scan) spectra of (A) MEB, (B) RMEB, (C) HMEB and (D) IS.
Validation results of the multi-residue method for the determination of mebendazole in pork, chicken, and horse muscles.
| Analyte | Internal standard | Spiking level, μg/kg | Recovery, % | Repeatability, CV, % | Within-laboratory reproducibility, CV, % | CCα | CCβ | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ⅰ | Ⅱ | Ⅲ | ||||||||||||||
| Pork | MEB | HMEB-D3 | 15 | 30 | 60 | 101.28 | 94.08 | 91.06 | 4.46 | 3.43 | 11.23 | 5.24 | 5.75 | 10.38 | 16.43 | 17.96 |
| RMEB | 99.33 | 93.81 | 91.06 | 5.59 | 4.82 | 10.52 | 6.85 | 6.93 | 10.72 | |||||||
| HMEB | 97.36 | 91.44 | 88.35 | 4.32 | 4.55 | 11.02 | 6.67 | 7.41 | 10.44 | |||||||
| ∑MEB | 99.32 | 93.11 | 90.16 | 4.79 | 4.27 | 10.92 | 6.64 | 5.73 | 6.16 | |||||||
| Chicken | MEB | HMEB-D3 | 15 | 30 | 60 | 93.86 | 89.85 | 91.03 | 6.41 | 6.35 | 5.22 | 8.80 | 5.49 | 6.95 | 15.84 | 17.94 |
| RMEB | 91.00 | 91.63 | 93.91 | 6.72 | 5.43 | 5.73 | 8.81 | 6.18 | 7.51 | |||||||
| HMEB | 89.81 | 90.86 | 94.53 | 8.90 | 3.50 | 6.46 | 9.89 | 4.56 | 8.87 | |||||||
| ∑MEB | 91.56 | 90.78 | 93.16 | 7.35 | 5.09 | 5.80 | 6.63 | 4.27 | 5.78 | |||||||
| Horse | MEB | HMEB-D3 | 15 | 30 | 60 | 96.42 | 100.25 | 94.56 | 7.65 | 9.94 | 8.18 | 6.80 | 8.39 | 9.68 | 15.97 | 17.60 |
| RMEB | 90.56 | 88.90 | 86.30 | 4.95 | 5.94 | 9.43 | 8.27 | 10.45 | 10.42 | |||||||
| HMEB | 100.03 | 96.63 | 95.23 | 5.86 | 8.52 | 10.06 | 5.71 | 8.65 | 10.17 | |||||||
| ∑MEB | 95.67 | 95.26 | 92.03 | 6.15 | 8.13 | 9.23 | 5.68 | 7.89 | 5.72 | |||||||
Fig 5HPLC-MS/MS chromatograms of (A) standard, (B) pork, (C) chicken, and (D) horse fortified with MEB, RMEB, HMEB, and IS at 30 μgkg-1.
Linear regression equations and correlation coefficients of standard curves for mebendazole and its metabolites.
| Analyte | Linear equation | Correlation coefficient value (r2) | |
|---|---|---|---|
| Pork | MEB | Y = 0.167X-0.128 | 0.999 |
| RMEB | Y = 0.0232X-0.0207 | 0.999 | |
| HMEB | Y = 0.0151X-0.0103 | 0.999 | |
| Chicken | MEB | Y = 0.156X-0.131 | 0.999 |
| RMEB | Y = 0.0209X-0.0226 | 0.999 | |
| HMEB | Y = 0.0149X-0.00269 | 0.999 | |
| Horse | MEB | Y = 0.156X-0.131 | 0.999 |
| RMEB | Y = 0.0209X-0.0226 | 0.999 | |
| HMEB | Y = 0.0149X-0.00269 | 0.999 |
aThe concentration ranged from 5 to 90 ugkg-1.
bY = AX + B, where Y is peak area and X is the concentration of the analyte.
ANOVA results for the linearity of MEB, RMEB, and HMEB.
| Analyte | Source of variation | Sum of Squares | Degree of Freedom | Mean Sum of Squares | F-ratio |
|---|---|---|---|---|---|
| MEB | Regression | 2.87 x 1013 | 1 | 2.87 x 1013 | 0.0025 |
| Residual | 5.14 x 1013 | 18 | 2.86 x 1012 | ||
| Lack of fit | 2.56 x 1010 | 3 | 8.53 x 1009 | ||
| Pure error | 5.14 x 1013 | 15 | 3.43 x 1012 | ||
| Total | 8.01 x 1013 | 19 | |||
| RMEB | Regression | 8.47 x 1012 | 1 | 8.47 x 1012 | 0.1795 |
| Residual | 2.11 x 1011 | 18 | 1.17 x 1010 | ||
| Lack of fit | 7.33 x 1009 | 3 | 2.44 x 1009 | ||
| Pure error | 2.04 x 1011 | 15 | 1.36 x 1010 | ||
| Total | 8.68 x 1012 | 19 | |||
| HMEB | Regression | 3.36 x 1012 | 1 | 3.36 x 1012 | 0.0186 |
| Residual | 6.72 x 1011 | 18 | 3.73 x 1010 | ||
| Lack of fit | 2.48 x 1009 | 3 | 8.28 x 1008 | ||
| Pure error | 6.69 x 1011 | 15 | 4.46 x 1010 | ||
| Total | 4.03 x 1012 | 19 |
The critical value of F-ratio is 3.2873 at alpha = 0.05.
Summary of purchase region, numbers of collected samples, and mebendazole residues results.
| Cities | Pork | Chicken | Horse | Total |
|---|---|---|---|---|
| Seoul | 19 (ND | 14 (1D | – | 33 (1D) |
| Busan | 7 (ND) | 6 (ND) | – | 13 (ND) |
| Incheon | 5 (ND) | 5 (ND) | – | 10 (ND) |
| Daegu | 5 (ND) | 3 (ND) | – | 8 (ND) |
| Gwangju | 3 (ND) | 3 (ND) | – | 6 (ND) |
| Daejeon | 3 (ND) | 2 (ND) | – | 5 (ND) |
| Ulsan | 3 (ND) | 2 (ND) | – | 5 (ND) |
| Jaeju | – | – | 6 (ND) | 6 (ND) |
| Total | 45 (ND) | 35 (1D) | 6 (ND) | 86 (1D) |
aND: not detected.
b1D: mebendazole residue detected from 1 sample.